I know iADT versus continuous ADT has been discussed so perhaps following may be helpful:
practiceupdate.com/c/124036...
TAKE-HOME MESSAGE
Intermittent androgen deprivation therapy (IADT) has been shown to be noninferior to continuous ADT, but real-world utilization of this strategy is not well-known. The authors of this retrospective study evaluated 8544 men older than 65 years with prostate cancer and undergoing ADT. Mean follow-up was 8.3 years. IADT was used in 16.4% of the population. Men more likely to undergo IADT included those with prior local therapy and those in the highest income quintile. At the provider level, radiation oncologists were more likely to use IADT as were providers with more than 10 years experience.
These data suggest that IADT may be an underutilized strategy, although this study is limited by the typical constraints of using an administrative database. Differences in utilization based on economic status may suggest that there are other ethnic or social differences between those undergoing continuous and intermittent ADT.
– Michael H. Johnson, MD